Peter Altman

BioCardia Lifesciences, Inc. engages in the development of therapeutics for cardiovascular diseases. The company is headquartered in Los Angeles, CA.

Lumen Therapeutics is an American biopharmaceutical company. The private company was founded by Peter Alan Altman.

BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA.

Ventritex, Inc. designs, develops, manufactures and markets implantable defibrillators and related products for the treatment of ventricular tachycardia and ventricular fibrillation.

Sinus Rhythm Technologies, Inc. develops devices for the prevention of atrial fibrillation. It treats causes of atrial fibrillation with an implanted apparatus that creates scar tissue and blocks electrical current. The company was founded by Robert A. van Tassel and Daniel J. Sullivan is headquartered in Plymouth, MN.